Skip to main content

Multiple Myeloma

CANDOR Study: Subgroup Analysis of Carfilzomib and Dexamethasone with or without Daratumumab in RRMM

Belantamab Mafodotin Combined with Pomalidomide and Dexamethasone for RRMM: A Dose-Finding Study

DREAMM-2 Study Evaluated Belantamab Mafodotin in Patients with RRMM: Prior Therapy Analysis

In Patients with RRMM, Circularly Permuted TRAIL, a Novel TRAIL Agonist, Is Combined with Thalidomide and Dexamethasone

GMMG-HD6 Study: Bortezomib, Lenalidomide, and Dexamethasone with or without Elotuzumab for Patients with Newly Diagnosed MM

Isatuximab for Patients with Previously Treated AL Amyloidosis: A Phase 2 Study

IKEMA Interim Analysis: Depth of Response and Response Kinetics of Isatuximab plus Carfilzomib and Dexamethasone in Patients with RMM

ICARIA-MM Study: Isatuximab plus Pomalidomide and Dexamethasone in Patients with RRMM with Gain(1q21)

GMMG-Concept Trial: Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone in Treatment of Patients with High-Risk MM

Multiple Myeloma Year in Review Introduction

5
6
7
8
9
10
11

Page 8 of 11
Results 71 - 80 of 104